source
- Experts outline emerging radiopharmaceutical approaches for metastatic castration-resistant prostate cancerDr. Pedro Barata and Dr. Johann De Bono discuss the next steps for radiopharmaceutical therapies aimed at metastatic castration-resistant prostate cancer, highlighting how these agents could reshap…
- Experts discuss sequencing and patient selection for radiopharmaceuticals in advanced prostate cancerDr. Johann De Bono and Dr. Pedro Barata discuss how treatment sequencing is evolving for radiopharmaceuticals in metastatic castration-resistant prostate cancer. They highlight the need to match p…